Sopharma Trading AD (BUL:SFT)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

3.140

+0.020 (0.64%)

At close: Oct 2, 2026

Sopharma Trading AD Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,252	1,173	1,000	858.14	757.95	683.08
Revenue Growth	13.12%	17.32%	16.56%	13.22%	10.96%	15.58%
Gross Profit	165.67	160.48	128.01	100.21	87.99	72.79
Operating Income	36.36	41.13	30.78	22.86	20.38	8.21
Net Income	24.09	29.71	20.64	14.93	4.64	4.12
Earnings Per Share	0.71	0.87	0.60	0.44	0.14	0.12
EPS Growth	-18.92%	44.88%	38.41%	221.74%	12.75%	-29.83%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Medicinal and Medical Products	1,228	1,151	975.23	845.05	748.69	674.03
Medical Equipment	-	15.98	20.17	10.5	7.08	9.05
Total	1,244	1,167	995.4	855.56	755.77	683.08

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	4.35	7.86	7.01	6.7	3.49	5.98
Total Debt	182.2	178.35	142.22	128.75	129.59	138.56
Net Cash (Debt)	-177.84	-170.49	-135.21	-122.05	-126.1	-132.58
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5.21	-5.01	-3.95	-3.56	-3.68	-3.87

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	32.15	-2.16	35.31	24.52	9.5	-88.39
Capital Expenditures	-8.64	-8.61	-7.3	-5.28	-2.93	-3.85
Free Cash Flow	23.51	-10.77	28.01	19.24	6.56	-92.24
Free Cash Flow Growth	-	-	45.57%	193.07%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	13.23%	13.68%	12.80%	11.68%	11.61%	10.66%
Operating Margin	2.90%	3.50%	3.08%	2.66%	2.69%	1.20%
Pretax Margin	2.36%	3.05%	2.41%	2.04%	0.84%	0.71%
Profit Margin	1.92%	2.53%	2.06%	1.74%	0.61%	0.60%
FCF Margin	1.88%	-0.92%	2.80%	2.24%	0.87%	-13.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	4.45	3.38	4.93	7.04	22.65	22.35
Forward PE	-	12.90	12.90	12.90	12.90	12.90
P/FCF Ratio	4.51	-	3.64	5.47	16.01	-
PS Ratio	0.08	0.09	0.10	0.12	0.14	0.14